An evaluation of co-use of chloroquine or hydroxychloroquine plus azithromycin on cardiac outcomes: A pharmacoepidemiological study to inform use during the COVID19 pandemic

BACKGROUND: Chloroquine or hydroxychloroquine (chloroquine) plus azithromycin is considered as therapy for COVID-19. With benefit evaluations underway, safety concerns due to potential additive effects on QTc prolongation should be addressed. OBJECTIVE: We compared risk of cardiac adverse events bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Vouri, Scott M., Thai, Thuy N., Winterstein, Almut G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190482/
https://www.ncbi.nlm.nih.gov/pubmed/32409150
http://dx.doi.org/10.1016/j.sapharm.2020.04.031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190482/
https://www.ncbi.nlm.nih.gov/pubmed/32409150
http://dx.doi.org/10.1016/j.sapharm.2020.04.031

Ejemplares similares